Cisgender women with HIV in the United States: how have HIV care continuum outcomes changed over time? 2015-2020

Objective:To evaluate HIV care continuum trends over time among women with HIV (WWH).Design:The Medical Monitoring Project (MMP) is a complex sample survey of adults with diagnosed HIV in the United States.Methods:We used 2015-2019 MMP data collected from 5139 adults with diagnosed HIV infection who identified as cisgender women. We calculated weighted percentages with 95% confidence intervals (CIs) for all characteristics and estimated annual percentage change (EAPC) and the associated 95% CI to assess trends. EAPCs were considered meaningful from a public health perspective if at least 1% with P values less than 0.05.Results:Among cisgender women with diagnosed HIV infection during 2015-2019, 58.8% were Black or African American (95% CI 54.4-63.3), 19% were Hispanic/Latina (95% CI 14.7-23.2), and 16% were Non-Hispanic White (95% CI 14.1-17.9) persons. There was a meaningful increase in the percentage who ever had stage 3 HIV disease from 55.8% (95% CI 51.0-60.5) in 2015 to 61.5% (95% CI 58.1-64.8) in 2019 (EAPC 1.7%; CI 1.5-1.9; P < 0.001). There were no meaningful changes over time among women, overall, in retention in care, antiretroviral therapy (ART) prescription, ART adherence, missed appointments, or recent or sustained viral suppression.Conclusion:The HIV care continuum outcomes among WWH did not meaningfully improve from 2015 to 2019, raising a concern that Ending the HIV Epidemic in the US (EHE) initiative goals will not be met. To improve health and reduce transmission of HIV among WWH, multifaceted interventions to retain women in care, increase ART adherence, and address social determinants of health are urgently needed.

Automated summary

This study found that there was no meaningful improvement in HIV care continuum outcomes among women with HIV from 2015 to 2019 in the United States, raising concerns about the achievement of Ending the HIV Epidemic in the US (EHE) initiative goals. To improve the health of women with HIV and reduce HIV transmission, multifaceted interventions including retaining women in care, increasing antiretroviral therapy adherence, and addressing social determinants of health are urgently needed.